Thomas Jefferson University

Jefferson Digital Commons
Division of Infectious Diseases and
Environmental Medicine Faculty Papers

Division of Infectious Diseases and
Environmental Medicine

11-23-2021

Fever in a returning traveler: A case and literature review of
melioidosis
Akanksha Arya
Thomas Jefferson University

Hamadullah Shaikh
Thomas Jefferson University

Devin Weber
Thomas Jefferson University

Matthew Pettengill
Thomas Jefferson University

Sean Moss

Follow
and additional
works at: https://jdc.jefferson.edu/didem
Thomasthis
Jefferson
University
Part of the Infectious Disease Commons

Let us know how access to this document benefits you
Recommended Citation
Arya, Akanksha; Shaikh, Hamadullah; Weber, Devin; Pettengill, Matthew; and Moss, Sean, "Fever
in a returning traveler: A case and literature review of melioidosis" (2021). Division of Infectious
Diseases and Environmental Medicine Faculty Papers. Paper 11.
https://jdc.jefferson.edu/didem/11
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been
accepted for inclusion in Division of Infectious Diseases and Environmental Medicine Faculty Papers by an
authorized administrator of the Jefferson Digital Commons. For more information, please contact:
JeffersonDigitalCommons@jefferson.edu.

IDCases 26 (2021) e01340

Contents lists available at ScienceDirect

IDCases
journal homepage: www.elsevier.com/locate/idcases

Case report

Fever in a returning traveler: A case and literature review of melioidosis
⁎

Akanksha Arya, Hamadullah Shaikh , Devin Weber, Matthew Pettengill, Sean Moss

]]

]]
]]]]]]

Thomas Jefferson University Hospital, 111 S 11th St, Philadelphia, PA 19107, United States

a r t i cl e i nfo

a bstr ac t

Article history:
Received 29 October 2021
Received in revised form 12 November 2021
Accepted 13 November 2021

Burkholderia pseudomallei is an aerobic, motile, non-spore-forming gram-negative bacillus found in tropical
endemic environments that causes the disease melioidosis. Melioidosis displays a diversity of clinical
presentations ranging from septic shock to chronic latent infection, often with characteristic abscesses in
multiple organs. Melioidosis is an opportunistic infection, with risk factors, including diabetes, alcohol use,
chronic lung disease, and chronic renal disease, and these risk factors increase the severity of disease
(Wiersinga et al., 2006) [1]. In this case report, we illustrate a case of a 32 year old man with several risk
factors and recent travel to an endemic region presenting with melioidosis. Our case demonstrates the
challenges in obtaining a diagnosis in a non-endemic location, highlights a complex presentation of this
disease, and describes the multifaceted clinical management required to care for this patient. As global
travel increases, there is an increased need for clinician awareness of this disease in non-endemic regions.
© 2021 The Authors. Published by Elsevier Ltd.
CC_BY_4.0
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Introduction
Burkholderia pseudomallei is an aerobic, motile, non-sporeforming gram-negative bacillus found in the environment of endemic tropical areas [1]. While well-known to be present in Southeast Asia and Northern Australia, Burkholderia pseudomallei is also
endemic in other tropical areas, including the Indian subcontinent,
China, equatorial Africa, Central and South America. Though not
endemic to the contiguous United States, endemic cases have been
found in Puerto Rico [3] and cases associated with travel to Mexico
have been found in the Southwestern US [4]. Recently, cases were
described in the US for patients who had not traveled to endemic
areas, although the source of these non-travel related cases has not
been identified [4]. The majority cases of melioidosis in the United
States have been found in patients with documented travel to endemic areas [6]. Burkholderia pseudomallei is classified as a Tier 1
biological select agent and toxin by the CDC [7].
Case
A 32-year-old male initially presented with two-week of generalized weakness, fever, and non-bloody diarrhea at an outside
institution. Patient had past medical histories of type-2 diabetes,
hyperlipidemia, non-alcoholic fatty liver disease, and SARS CoV-2
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infection. He recently returned from Bangladesh. The laboratory
results from outside institution were significant for severe hyponatremia (sodium 108 mEq/l), elevated D-dimer (11.9 mcg/ml), elevated
ESR (109 mm/h), acute kidney injury, and thrombocytopenia.
Subsequently, patient developed hypoxic respiratory failure for
which he was intubated. CT chest showed development of extensive
bilateral alveolar opacities with subpleural sparing. CT abdomen
demonstrated hepatosplenomegaly with associated hepatic and
splenic abscesses, splenic vein thrombosis, and multiple splenic infarcts. Preliminary blood cultures grew gram negative rods initially
reported as Acinetobacter baumannii. Transthoracic echocardiogram
was negative for vegetations. After receiving multiple doses of empiric antibiotics, patient was ultimately treated with meropenem,
levofloxacin, and metronidazole and transferred to our institution
due to a complex clinical course.
On admission to our hospital, patient was found to be hypotensive with BP of 80/40. Physical exam was significant for coarse breath
sounds in bilateral lung fields; a hyperpigmented, desquamating
lower extremity rash; and a 4.5 cm enlarged right axillary lymph
node. Antibiotics were changed to meropenem and minocycline
based on initial blood cultures from outside hospital. Repeat blood
cultures were ordered which were positive, one with a Gram stain of
Gram negative bacilli, and another bottle with a Gram stain of Gram
positive cocci. The bottle with Gram negative bacilli was tested on a
multiplex PCR assay for common organisms causing bloodstream
infections which identified Pseudomonas aeruginosa. The blood culture with Gram positive cocci subsequently grew Staphylococcus
hominis, most likely a blood culture contaminant. The identification
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of Pseudomonas by PCR was subsequently determined to be a falsepositive result, related to residual organism DNA in sterilized but
DNA contaminated blood culture media. A correction of the initial
blood cultures was called from outside institution and identified as
possible Burkholderia pseudomallei, which was eventually confirmed
by PCR at the state laboratory. We informed our microbiology lab
about this update from the outside hospital microbiology laboratory.
Our microbiology lab used a rule out procedure to analyze cultures
drawn at our institution and was not able to rule out Burkholderia
pseudomallei – characteristic safety pin morphology on Gram stain,
growth on MacConkey agar, oxidase positive and spot indole negative, no hemolysis on blood agar, non-pigmented – referring final
identification to the state public health laboratory.
Based on culture results and clinical presentation, antibiotics
were changed to meropenem and trimethroprim-sulfamethoxazole.
Patient’s course in the ICU was complicated by acute respiratory
distress syndrome, and diffuse alveolar hemorrhage, which later
resolved. Splenic vein thrombus was treated with anticoagulation,
and thrombocytopenia was assessed to be secondary to splenic sequestration. Splenic and hepatic abscesses were evaluated by interventional radiology and were assessed to be too small to drain.
Patient’s clinical course improved, repeat blood cultures were negative, and patient was able to be downgraded from the ICU. Three
members of the microbiology lab staff were exposed to the blood or
respiratory B. pseudomallei cultures outside of a biosafety cabinet
(BSC) and were offered trimethroprim-sulfamethoxazole prophylaxis. Of note, one of the three technologists was subsequently
hospitalized, not due to infection, but rather severe allergic reaction
to trimethroprim-sulfamethoxazole. None of the three technologists
sero-converted to produce antibodies to B. pseudomallei. The patient
was later discharged with a tracheostomy, a PEG tube, and close
follow up. On discharge, patient continued meropenem for an intensive phase of four weeks and trimethroprim-sulfamethoxazole
for an eradication phase of four months after getting sensitivities
back from CDC and the isolate was susceptible to Ceftazidime,
Meropenem and Trimethoprim-Sulfamethoxazole. Repeat CT abdomen/pelvis one and half months after presentation showed resolution of lung infiltrates, improvement in splenic abscesses,
improvement in previously seen left hepatic lobe abscesses, and
development of new right hepatic lobe lesions concerning for ongoing infection. However, during this follow up visit, patient’s tracheostomy and PEG tube had been removed. Patient continued
taking his Trimethroprim-Sulfamethoxazole and a CT scan 3 months
later showed resolution of all hepato-splenic abscesses and the patient was stable without any reported symptoms.

with skin abrasions. Person-to-person transmission is rare [9]. Incubation period generally ranges from one to twenty-one days,
however, an incubation period as long as 62 years have been identified in one case [10,11]. Route of transmission can impact severity
of disease, with inhalation associated with pneumonia and more
severe disease compared to other modes of transmission [10].
However, the greatest predictor for severe disease and mortality in
patients with melioidosis is presence of risk factors. The largest risk
factor for mortality from melioidosis is diabetes, followed by alcohol
use, chronic lung disease, and chronic renal disease [13]. Diabetes
was our patient’s greatest risk factor and likely contributed to his
severe disease.
Though an unusual presentation for regularly found gram-negative infections in the US, our patient’s presentation was classic for
severe melioidosis. Melioidosis is characterized by internal organ
abscesses, and can include sepsis, pneumonia, skin infection, and
neurological presentation [13]. Though initially with a nonspecific
presentation, our patient quickly developed pneumonia, sepsis and
skin lesions. Abscesses in liver and spleen initially raised suspicion
for endocarditis, however, TTE was negative. These later were determined to be the characteristic internal organ abscesses seen in
melioidosis.
Melioidosis is often underdiagnosed due to lack of clinician
awareness and lack of laboratory technology in rural communities in
endemic areas. In non-endemic areas, laboratories can accidentally
misidentify the pathogen or mischaracterize it as a contaminant
[15]. Laboratory misidentification occurred in our case, with preliminary laboratory reports reporting Acinetobacter baumannii (admission hospital blood culture) and Pseudomonas aeruginosa (at our
institution). Abnormal presentation, poor response to antibiotics
targeting preliminarily reported pathogens, and reporting of varied
pathogens appropriately prompted follow up with the laboratory.
The state public health laboratory correctly identified Burkholderia
pseudomallei and cultures were sent to the CDC for sensitivity
testing. As non-culture based methods to diagnose melioidosis are
not well established, clinical suspicion and laboratory rule-out procedures and subsequent referral to appropriate public health labs for
final identification remains key to making the diagnosis. Burkholderia pseudomallei is not a part of normal human flora, and
isolation on any culture is diagnostic. Taking multiple samples, including blood, throat, rectal, urine, abscess, and sputum, increases
the rate of success in making the diagnosis. Burkholderia pseudomallei grows more slowly than most organisms, so agar plates with
samples from suspected patients should be incubated and examined
daily for up to four days [3]. CT imaging is also highly recommended
due to high incidence of multiple organ abscesses. Early diagnosis
and treatment is key to reducing mortality.
Antibiotic therapy for melioidosis comprises an initial intensive
phase and then a longer eradication phase. Initial intensive phase
should last a minimum of 10–14 days and longer in patients with
more severe disease, such as this patient [3]. Intensive phase therapy
should be with ceftazidime or meropenem. Ceftazidime is often the
initial antibiotic chosen for most patients, however, meropenem has
been shown to have better outcomes in patients with severe sepsis
and is recommended for more severe disease [18]. Due to our patient’s severe presentation, he was treated with meropenem for four
weeks. Singular large abscesses should be drained if possible.
However, often abscesses are too numerous and small to be drained,
as was the case for this patient. The eradication phase with oral
antibiotics is done to prevent recrudescence or relapse. Trimethoprim-sulfamethoxazole is the preferred agent because of excellent
tissue penetration, and therapy is recommended for 3–6 weeks.
Recrudescence can be seen with noncompliance with antibiotics, a
shortened intensive or eradication phase, or incomplete drainage of
abscesses [3]. As this patient’s abscesses were not drainable, he is at
risk for recrudescence. New lesions seen on follow up in this patient

Discussion
This case highlights the importance of provider awareness and
clinical suspicion of melioidosis when treating traveling patients
with disseminated gram negative bacterial infections. Because
Burkholderia pseudomallei is not endemic to the US, preliminary laboratory analysis may misidentify this pathogen in cultures. Sepsis,
pneumonia, skin infections, and disseminated internal organ abscesses in a patient who has traveled from the tropics should raise
clinician suspicion for melioidosis and prompt collaboration with
microbiology laboratory to ensure an appropriate diagnosis.
Infection in this patient who recently traveled from Bangladesh
should raise suspicion for an emerging infection. Though melioidosis
is classically associated with Southeast Asia and northern Australia,
it is also endemic to Bangladesh. Similar to our patient, cases in
Bangladesh have been young in men with a median age of 45. While
most cases are seen in the rainy season of June-October, some cases
have been seen in the winter months, around the time this patient
traveled [8]. The pathogen is harbored in contaminated dust and
water, and is transmitted through inhalation, ingestion, or contact
2
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increase concern for continued active infection, and this patient will
require prolonged treatment and monitoring.
Of note, while B. pseudomallei has important biosafety considerations to prevent infections in laboratory staff due to exposure
from handling the organism outside of biocontainment before the
organism is suspected or identified, a recent study found that the
risk of lab acquired infection with B. pseudomallei following standard
diagnostic procedures may be relatively low [20]. In our case none of
the technologists seroconverted, and one had a considerable adverse
reaction to the prophylactic antibiotics.
In summary, melioidosis is an emerging infection that should be
considered in patients that have traveled to endemic areas, present
with abnormal gram-negative infection, and display typical clinical
signs of disease including internal organ abscesses, pneumonia, and
sepsis. Clinical suspicion and accurate laboratory identification is
critical for early diagnosis and treatment. Severe disease and varied
abscesses increase the challenge of management, and patients with
complex and severe disease require prolonged antibiotic therapy and
monitoring. As global travel increases, melioidosis cases can be expected to increase in the US, requiring a need for increased clinician
awareness of this disease.
Written informed consent was obtained from the patient for
publication of this case report and accompanying images. A copy of
the written consent is available for review by the Editor-in-Chief of
this journal on request.
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